Advanz Pharma Is A Global Pharmaceutical Company Headquartered In Londonukit Operates In Over 90 Countrieswith A Direct Commercial Presence In More Than 20 Countriesincluding Europethe Uscanadaand Australiathe Company Specializes In Commercializing Specialtyhospitaland Rare Disease Medicinespartnering With Biopharma Firms To Improve Patient Access The Product Portfolio Includes Innovative Medicines For Rare Diseasesspecialty Genericsbiosimilarsand Established Therapies In Areas Such As Hepatologygastroenterologyanti Infectivesand Endocrinologyadvanz Pharma Has A Strong Focus On Therapeutic Areas Like Critical Careanti Infectivescnscardiovascularand Rare Diseasesthe Company Has Made Significant Strides Recentlyincluding Acquiring Intercept Pharmaceuticalsae European And Canadian Operations And Partnering With Alvotech To Commercialize Biosimilars In Europewith A Revenue Of A 805 Million And Over 700 Employeesadvanz Pharma Is Well Positioned In The Pharmaceutical Industry
